Skip to content

Study Comparing Pulmonary Vein Isolation With the Cryoballoon and Radiofrequency Energy(Contact Force) in the Treatment of Persistent Atrial Fibrillation (AF) (Cryo Vs CF in PerAF)

Study Comparing Pulmonary Vein Isolation With the Cryoballoon and Radiofrequency Energy(Contact Force) in the Treatment of Persistent Atrial Fibrillation (PerAF)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03053570
Enrollment
200
Registered
2017-02-15
Start date
2017-03-01
Completion date
2018-12-31
Last updated
2017-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Atrial Fibrillation

Keywords

Cryoballoon, Contact Force, Persistent Atrial Fibrillation

Brief summary

The purpose of this study is to perform a prospective, randomised study investigating the safety and efficacy of cryoballoon catheter ablation compared with radiofrequency ablation(contact force), in the treatment of persistent AF.

Detailed description

The hypotheses for this study is that cryothermal energy is as effective and safe as using radiofrequency energy in the treatment of persistent AF and is associated with a better long term outcome.

Interventions

use Cryoballoon to isolation the Pulmonary Vein

DEVICERadiofrequency Energy(Contact Force)

use Radiofrequency Energy(Contact Force) to isolation the Pulmonary Vein

Sponsors

China Cardiometabolic Registries
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* persistent Atrial Fibrillation; Intolerant to antiarrhythmic medication; Both male or female; Age from 18 to 75 years old.

Exclusion criteria

* Acute myocardial infarction; Coronary artery stent history; Acute severe stroke; Abnormal liver and renal function.

Design outcomes

Primary

MeasureTime frame
Number of participants with successful Pulmonary Vein Isolationin one year

Countries

China

Contacts

Primary ContactBaopeng Tang, PhD
tangbaopeng1111@163.com+86 13579881111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026